Nuvation Bio Revenue and Competitors
Estimated Revenue & Valuation
- Nuvation Bio's estimated annual revenue is currently $12.7M per year.
- Nuvation Bio's estimated revenue per employee is $230,236
- Nuvation Bio's total funding is $777M.
- Nuvation Bio's current valuation is $1.3B. (January 2022)
Employee Data
- Nuvation Bio has 55 Employees.
- Nuvation Bio grew their employee count by 22% last year.
Nuvation Bio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder, President and CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Chief Commercial Officer | Reveal Email/Phone |
4 | VP, Head Data Science | Reveal Email/Phone |
5 | VP Chemistry | Reveal Email/Phone |
6 | VP, Legal | Reveal Email/Phone |
7 | VP, Clinical Research Physician | Reveal Email/Phone |
8 | VP, Head Clinical Operations | Reveal Email/Phone |
9 | Executive Director, Clinical Research | Reveal Email/Phone |
10 | Associate Director, Stock and 401k Administration | Reveal Email/Phone |
Nuvation Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.3M | 61 | 7% | N/A | N/A |
#2 | $354.3M | 461 | -2% | $567.1M | N/A |
#3 | $377.1M | 1876 | -1% | N/A | N/A |
#4 | $7.8M | 39 | 8% | N/A | N/A |
#5 | $5.4M | 27 | 0% | N/A | N/A |
#6 | $45M | 224 | 6% | N/A | N/A |
#7 | $6.8M | 34 | -82% | N/A | N/A |
#8 | $9.2M | 46 | 12% | N/A | N/A |
#9 | N/A | 694 | 46% | N/A | N/A |
#10 | $15.5M | 77 | 5% | N/A | N/A |
What Is Nuvation Bio?
Nuvation Bio is a biopharmaceutical company focused on revolutionizing cancer treatment by discovering, developing and delivering therapies that tackle some of the greatest needs in oncology. Nuvation Bio's proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world's leading prostate cancer medicines. Nuvation Bio has offices in New York and San Francisco.
keywords:N/A
$777M
Total Funding
55
Number of Employees
$12.7M
Revenue (est)
22%
Employee Growth %
$1.3B
Valuation
N/A
Accelerator
Nuvation Bio News
Zero analysts have provided estimates for Nuvation Bio's earnings, with the highest EPS estimate coming in at ($0.14) and the lowest estimate...
Overall market sentiment has been down on Nuvation Bio Inc (NUVB) stock lately. NUVB receives a Bearish rating from InvestorsObserver Stock...
Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel...
NEW YORK, Nov. 10, 2021 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported financial results for the third quarter ended September 30, 2021 ...
NEW YORK, Aug. 12, 2021 /PRNewswire/ -- Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today reported financial results for the second quarter ended June 30, 2021, an ...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6.2M | 55 | 31% | $18.9M |
#2 | $10.1M | 55 | 15% | N/A |
#3 | $5.9M | 55 | 12% | N/A |
#4 | $9.9M | 55 | -4% | N/A |
#5 | $11.2M | 55 | 6% | N/A |